Cancer-associated fibroblasts in the single-cell era.


Journal

Nature cancer
ISSN: 2662-1347
Titre abrégé: Nat Cancer
Pays: England
ID NLM: 101761119

Informations de publication

Date de publication:
07 2022
Historique:
received: 09 09 2021
accepted: 14 06 2022
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 29 7 2022
Statut: ppublish

Résumé

Cancer-associated fibroblasts (CAFs) are central players in the microenvironment of solid tumors, affecting cancer progression and metastasis. CAFs have diverse phenotypes, origins and functions and consist of distinct subpopulations. Recent progress in single-cell RNA-sequencing technologies has enabled detailed characterization of the complexity and heterogeneity of CAF subpopulations in multiple tumor types. In this Review, we discuss the current understanding of CAF subsets and functions as elucidated by single-cell technologies, their functional plasticity, and their emergent shared and organ-specific features that could potentially be harnessed to design better therapeutic strategies for cancer.

Identifiants

pubmed: 35883004
doi: 10.1038/s43018-022-00411-z
pii: 10.1038/s43018-022-00411-z
pmc: PMC7613625
mid: EMS145989
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-807

Subventions

Organisme : Worldwide Cancer Research
ID : 20-0169
Pays : United Kingdom

Informations de copyright

© 2022. Springer Nature America, Inc.

Références

Cancers (Basel). 2015 Sep 29;7(4):1994-2011
pubmed: 26426054
Cells. 2019 May 24;8(5):
pubmed: 31137713
Cell Rep. 2020 May 19;31(7):107628
pubmed: 32433953
Cancer Metastasis Rev. 2021 Sep;40(3):675-689
pubmed: 34591240
Nat Methods. 2009 May;6(5):377-82
pubmed: 19349980
Nat Commun. 2020 Oct 8;11(1):5077
pubmed: 33033240
iScience. 2019 Mar 29;13:328-338
pubmed: 30878879
J Pathol. 2013 Dec;231(4):517-31
pubmed: 24114721
Nat Cell Biol. 2021 Jan;23(1):87-98
pubmed: 33420488
Cancer Res. 2007 Nov 1;67(21):10123-8
pubmed: 17974953
J Pathol. 2019 May;248(1):51-65
pubmed: 30575030
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
JCI Insight. 2019 Jul 23;5:
pubmed: 31335328
Nat Commun. 2018 Dec 4;9(1):5150
pubmed: 30514914
Nat Commun. 2021 Jun 17;12(1):3709
pubmed: 34140509
Cancer Discov. 2019 Feb;9(2):282-301
pubmed: 30366930
Cell Rep. 2018 Mar 27;22(13):3625-3640
pubmed: 29590628
PLoS One. 2012;7(2):e30563
pubmed: 22363446
Cell Mol Life Sci. 2016 Mar;73(6):1145-57
pubmed: 26681260
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
J Hepatol. 2020 Nov;73(5):1118-1130
pubmed: 32505533
Cancer Res. 2018 Jul 15;78(14):4059-4072
pubmed: 29764866
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Cell Rep. 2021 Apr 13;35(2):108945
pubmed: 33852842
Nat Rev Immunol. 2014 Nov;14(11):719-30
pubmed: 25324123
Sci Adv. 2021 Jan 27;7(5):
pubmed: 33571124
Genes Dev. 2016 May 1;30(9):1002-19
pubmed: 27151975
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
Prostate. 2020 Feb;80(2):173-185
pubmed: 31763714
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
BMC Biol. 2021 May 25;19(1):107
pubmed: 34030676
Genes Cancer. 2018 Mar;9(3-4):78-86
pubmed: 30108679
Nat Genet. 2015 Apr;47(4):320-9
pubmed: 25706628
Sci Rep. 2019 Jul 3;9(1):9580
pubmed: 31270426
Exp Dermatol. 2021 Jan;30(1):92-101
pubmed: 33237598
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Cancers (Basel). 2021 Jun 15;13(12):
pubmed: 34203869
Nat Commun. 2020 Sep 9;11(1):4516
pubmed: 32908137
J Clin Invest. 2021 Jun 1;131(11):
pubmed: 33905375
Cell Discov. 2020 Oct 6;6:69
pubmed: 33083004
Cancer Discov. 2016 Aug;6(8):886-99
pubmed: 27184426
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Nat Commun. 2021 Jul 21;12(1):4441
pubmed: 34290255
Cell Discov. 2021 May 25;7(1):36
pubmed: 34035226
Cancers (Basel). 2020 May 25;12(5):
pubmed: 32466266
Cancer Cell. 2022 Jun 13;40(6):656-673.e7
pubmed: 35523176
Nat Cancer. 2020 Jul;1(7):692-708
pubmed: 35122040
Cancer Res. 2018 Sep 1;78(17):4957-4970
pubmed: 29976575
Clin Cancer Res. 2019 Apr 1;25(7):2194-2205
pubmed: 30385653
Gut. 2022 Jan;71(1):185-193
pubmed: 33431577
Nat Commun. 2018 Mar 13;9(1):1056
pubmed: 29535360
Trends Cell Biol. 2022 Feb;32(2):110-123
pubmed: 34479765
Cancer Discov. 2020 Feb;10(2):232-253
pubmed: 31699795
Nat Med. 2020 Aug;26(8):1271-1279
pubmed: 32572264
Adv Sci (Weinh). 2020 Sep 24;7(21):2002518
pubmed: 33173749
Physiol Rev. 2021 Jan 1;101(1):147-176
pubmed: 32466724
Cancer Cell. 2021 Sep 13;39(9):1227-1244.e20
pubmed: 34297917
Front Immunol. 2019 Aug 02;10:1835
pubmed: 31428105
PLoS Biol. 2020 Dec 11;18(12):e3001032
pubmed: 33306673
Cancer Cell. 2021 Jun 14;39(6):866-882.e11
pubmed: 33930309
Sci Rep. 2021 Feb 25;11(1):4690
pubmed: 33633222
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Mol Syst Biol. 2020 Dec;16(12):e9682
pubmed: 33332768
Cancer Discov. 2022 Feb;12(2):484-501
pubmed: 34548310
Nat Genet. 2017 May;49(5):708-718
pubmed: 28319088
Cell Rep. 2021 Apr 20;35(3):109009
pubmed: 33882319
Cancer Res. 2021 Apr 1;81(7):1639-1653
pubmed: 33547159
PLoS One. 2018 Nov 1;13(11):e0206785
pubmed: 30383866
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Cancer Cell. 2021 Jul 12;39(7):928-944.e6
pubmed: 33961783
Nat Biotechnol. 2020 Mar;38(3):333-342
pubmed: 31932730
J Exp Med. 2018 Dec 3;215(12):3075-3093
pubmed: 30470719
Nat Commun. 2019 Feb 8;10(1):650
pubmed: 30737373
Elife. 2019 Mar 26;8:
pubmed: 30912746
Cancer Discov. 2022 Mar 1;12(3):670-691
pubmed: 34642171
Cell Res. 2019 Sep;29(9):725-738
pubmed: 31273297
Curr Opin Cell Biol. 2016 Oct;42:80-93
pubmed: 27214794
Clin Cancer Res. 2021 Apr 1;27(7):2023-2037
pubmed: 33495315
Cancers (Basel). 2020 Dec 04;12(12):
pubmed: 33291647
Cell. 2019 Jul 25;178(3):714-730.e22
pubmed: 31348891
Nat Med. 2017 Oct;23(10):1176-1190
pubmed: 28920957
Nature. 2021 May;593(7860):575-579
pubmed: 33981032
Dis Model Mech. 2018 Apr 19;11(4):
pubmed: 29686035
EBioMedicine. 2021 Apr;66:103315
pubmed: 33819739
Nat Commun. 2021 Apr 30;12(1):2567
pubmed: 33931654
Exp Mol Med. 2018 Aug 7;50(8):1-14
pubmed: 30089861
Nature. 2020 Apr;580(7804):524-529
pubmed: 32322056
Nat Med. 2018 Aug;24(8):1277-1289
pubmed: 29988129
EMBO J. 2020 Oct 1;39(19):e104063
pubmed: 32790115
Cell. 2019 Sep 5;178(6):1493-1508.e20
pubmed: 31474370
Cancer Biol Ther. 2006 Dec;5(12):1640-6
pubmed: 17106243
Genome Med. 2020 Sep 29;12(1):80
pubmed: 32988401
Cancer Discov. 2020 Sep;10(9):1330-1351
pubmed: 32434947
Cancer Cell. 2011 Feb 15;19(2):257-72
pubmed: 21316604
Nat Rev Cancer. 2021 Apr;21(4):217-238
pubmed: 33589810
J Clin Invest. 2017 Mar 1;127(3):780-789
pubmed: 28248200
Breast Cancer Res. 2020 Jul 14;22(1):76
pubmed: 32665033
PLoS One. 2016 Jul 26;11(7):e0159947
pubmed: 27459365
Nat Commun. 2020 Dec 7;11(1):6245
pubmed: 33288768
Cancer Res. 2015 Mar 15;75(6):963-73
pubmed: 25600648
Cancers (Basel). 2020 May 21;12(5):
pubmed: 32455670
Nat Commun. 2020 Jan 21;11(1):404
pubmed: 31964880

Auteurs

Dor Lavie (D)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Aviad Ben-Shmuel (A)

Department of Biomolecular Sciences, the Weizmann Institute of Science, Rehovot, Israel.

Neta Erez (N)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. netaerez@tauex.tau.ac.il.

Ruth Scherz-Shouval (R)

Department of Biomolecular Sciences, the Weizmann Institute of Science, Rehovot, Israel. ruth.shouval@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH